Table: begin end state 1 11 non-cytoplasmic 12 31 transmembrane 32 58 cytoplasmic 59 83 transmembrane 84 88 non-cytoplasmic 89 109 transmembrane 110 137 cytoplasmic 138 157 transmembrane 158 174 non-cytoplasmic 175 194 transmembrane 195 202 cytoplasmic 203 223 transmembrane 224 229 non-cytoplasmic 230 255 transmembrane 256 292 cytoplasmic 293 315 transmembrane 316 338 non-cytoplasmic 339 361 transmembrane 362 376 cytoplasmic 377 393 transmembrane 394 398 non-cytoplasmic 399 425 transmembrane 426 481 cytoplasmic
Input: >GFF5497 FitnessBrowser__WCS417:GFF5497 MLEVINDFLSGKVLIVLIVGLGGYFTIRSRFVQLRHFFHMFSVFKDSLKSSAGQLSSFQA LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFIECSLGQLYKRTDAEG TYRGGPAYYIQHGLQKRWLGMVMAFLLLVTFGFAFNGLQAHAVTHSLNNAFGLDTTYTGL ALAVLLGLVFIGGIKRIASIADLLVPVKTLVYIAVTLYVIVLQFDHVPAMLATIVKSAFG LDQAFGGLVGSAIIMGVKRGVFANEAGLGSAPNVAAVASVEHPIAQGVVQAFSVFLDTFV ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRMFISVALALFVFTSIMYNYY LGESNLRFLVGNNRKVLMGYRALVLVLIFWGSIENLSTVFAFADITMTMLAFVNLFALAF LFKIAMRILNDYDNQRAAGIKTPVFDSSQFPDLDLDRKAWPANPVKPEAATSAELNAQVQ R
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server